##  [# ETF Explainer: IHI](/sections/etf-report-departments/etf-explainer-ihi) 

 

# ETF Explainer: IHI

 

 

The U.S. medical devices space was a bit of a roller coaster.



 

 

 

 

 [![HeatherBell_green_bg](/sites/default/files/styles/author_image_icon/public/2023-03/heather2.png?itok=5J9vBlda)](/contributors/heather-bell) 

[By Heather Bell](/contributors/heather-bell)

 Apr 01, 2019

 Edited by: Heather Bell

 

 

     Share  <a class="a2a a2a_button_email"> Email </a><a class="a2a a2a_button_linkedin"> LinkedIn </a><a class="a2a a2a_button_facebook"> Facebook </a><a class="a2a a2a_button_x"> X (Twitter) </a> 

 

 

 

 

 

 

 

 

  
            googletag.cmd.push(function() {
                googletag.display('js-dfp-tag-article_page_302x26');
            });
    
    

 

 

  

 



 

 

  Loading 

 

 



 

 

**iShares U.S. Medical Devices ETF**Each month, we look at an ETF selected by ETF.com based on its performance and importance to investors. This month, we consider the performance of the $3.3 billion [iShares U.S. Medical Devices ETF (IHI)](/IHI), which tracks the stocks of U.S. distributors and manufacturers of medical devices. All the companies mentioned below are holdings in IHI, unless otherwise noted (\*).

[![ETFExplainerARKW](/sites/default/files/images/Magazines/ETF%20Report/2019/04/ETFExplainerIHI_fig1.jpg)](/sites/default/files/images/Magazines/ETF%20Report/2019/04/ETFExplainerIHI_fig1b.jpg)

*For a larger view, please click on the image above.*



**MAR 23** Technology stocks plunge amid trade war tensions, with medical robotics company Intuitive Surgical hit harder than many of the other companies held by IHI

**JUL 25** Thermo Fisher beat its revenue growth expectations for the second quarter by 22%. The company raised its 2018 forecast as a result.

**AUG 21** Shares of Medtronic surge nearly 5% to a record high after exceeding analyst expectations for its fiscal first quarter, largely driven by sales in its diabetes and heart devices

**SEP 24** Abbott Laboratories shares get a strong boost after a test involving its MitraClip implant to treat secondary mitral regurgitation, a complication of heart failure, sees good results.

**DEC 24** Becton Dickinson shares are weighed down by divestitures and high raw material costs, but tick up near the end of the month after the FDA approves one of its diagnostic tests.

**FEB 25** General Electric\* agrees to sell its biopharmaceutical unit to Danaher to the tune of $21.4 billion, with the deal expected to close by the end of the year.

*Source: Bloomberg. Data for 02/28/2018 to 02/28/2019*





 

 

 [ Heather Bell ](/contributors/heather-bell) 

 

 

  Heather Bell is a former managing editor of etf.com. She has also held editorial positions at Dow Jones Indexes and Lehman Brothers. Bell is a…   [View Bio](/contributors/heather-bell)

 



 

 


 Related Topics  [Healthcare](http://www.etf.com/topics/healthcare) 

 [Blackrock](http://www.etf.com/topics/blackrock) 

 [Equity](http://www.etf.com/topics/equity) 

 [Health Care Equipment &amp; Supplies](http://www.etf.com/topics/health-care-equipment-supplies) 

 [Healthcare](http://www.etf.com/topics/healthcare)